The bill was rejected or lapsed before becoming law.
Therapeutic Goods Amendment (2020 Measures No. 2) 2020
✦ Plain-English Summary
Therapeutic Goods Amendment (2020 Measures No. 2) Bill 2020
What it does
This law updates the rules for therapeutic goods (medicines and medical devices) in Australia. The main change lets pharmacists swap one prescription medicine for another when the original medicine is in serious short supply — for example, if a particular antibiotic runs out. The bill also introduces a tracking system for medical devices and makes several technical updates to how the government manages medicine approvals and imports.
Why it matters
During shortages (like those that happened during COVID), pharmacists can now help patients get treatment without waiting for the exact medicine their doctor prescribed. This keeps healthcare running more smoothly when supply problems hit.
Key details
- Pharmacist substitution: Only works when the Health Minister officially declares a serious shortage of a specific medicine in Australia (or a region)
- Medical device tracking: New system to identify and track medical devices more reliably across the supply chain
- Staged rollout: Most changes start the day after the law passes, but rules about restricted information (Schedule 5) don't kick in for 2 months, giving businesses time to prepare
Official Description
Amends the Therapeutic Goods Act 1989 to: enable pharmacists to substitute a different medicine for one that has been prescribed where there is a serious scarcity of the prescribed medicine; allow the making of regulations to establish a unique device identification database for the traceability and monitoring of medical devices in Australia; enable authorised employees in the Department of Health to obtain and possess prescription medicines, or unapproved therapeutic goods, without contravening state and territory laws; allow the making of regulations to prohibit the import, export, supply or manufacture of therapeutic goods that are prohibited under international agreements; ensure the timely availability of COVID-19 vaccines by enabling the secretary to consent to the importation and supply of registered or listed therapeutic goods that do not have their registration or listing number on the label; make amendments in relation to the operation of the data protection scheme for assessed listed medicines; and make minor and technical amendments.
Audit History
Introduced
9 Dec 2020
Last updated on APH
10 Apr 2026
Outcome date
19 Feb 2021
Last checked by Crossbench
4 days ago
Full text indexed
4 days ago
No formal division recorded
This bill passed by voice vote — parliament agreed without calling a formal count. A division is only recorded when a member explicitly requests one.
Constituent votes
Voting is closed — this bill has been decided by parliament.
No votes yet.
No votes were recorded for this bill.